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Abstract
NAD is a ubiquitous and essential metabolic redox cofactor which also functions as a substrate in certain regulatory
pathways. The last step of NAD synthesis is the ATP-dependent amidation of deamido-NAD by NAD synthetase (NADS).
Members of the NADS family are present in nearly all species across the three kingdoms of Life. In eukaryotic NADS, the core
synthetase domain is fused with a nitrilase-like glutaminase domain supplying ammonia for the reaction. This two-domain
NADS arrangement enabling the utilization of glutamine as nitrogen donor is also present in various bacterial lineages.
However, many other bacterial members of NADS family do not contain a glutaminase domain, and they can utilize only
ammonia (but not glutamine) in vitro. A single-domain NADS is also characteristic for nearly all Archaea, and its dependence
on ammonia was demonstrated here for the representative enzyme from Methanocaldococcus jannaschi. However, a
question about the actual in vivo nitrogen donor for single-domain members of the NADS family remained open: Is it
glutamine hydrolyzed by a committed (but yet unknown) glutaminase subunit, as in most ATP-dependent
amidotransferases, or free ammonia as in glutamine synthetase? Here we addressed this dilemma by combining
evolutionary analysis of the NADS family with experimental characterization of two representative bacterial systems: a two-
subunit NADS from Thermus thermophilus and a single-domain NADS from Salmonella typhimurium providing evidence that
ammonia (and not glutamine) is the physiological substrate of a typical single-domain NADS. The latter represents the most
likely ancestral form of NADS. The ability to utilize glutamine appears to have evolved via recruitment of a glutaminase
subunit followed by domain fusion in an early branch of Bacteria. Further evolution of the NADS family included lineage-
specific loss of one of the two alternative forms and horizontal gene transfer events. Lastly, we identified NADS structural
elements associated with glutamine-utilizing capabilities.
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Introduction
Nicotinamide adenine dinucleotide (NAD) serves both, as a
ubiquitous cofactor in hundreds of redox reactions and as a
substrate in a number of regulatory processes related to cell cycle
and longevity, calcium signaling, immune response, DNA repair,
etc. [1,2,3]. Due to its impact on nearly all aspects of metabolism,
NAD is essential for survival and several enzymes involved in its
biosynthesis have been recognized as potential drug targets [4,5].
One of these enzymes is NAD synthetase (NADS), which catalyzes
amidation of nicotinic acid adenine dinucleotide (NaAD) in the
last step of NAD synthesis. NADS was demonstrated to be
essential in a number of bacterial pathogens including Mycobac-
terium tuberculosis, Bacillus anthracis, Staphylococcus aureus, and Esche-
richia coli [5,6], and it is currently being pursued as a target for
antibiotic development [7,8]. At the same time, relatively rare
alternative variants of NAD biosynthetic pathways that bypass the
requirement of NADS were described in some Bacteria
[9,10,11,12] and in Eukaryotes [13].
NADS, a member of the N-type ATP pyrophosphatase family
[14], catalyzes the ATP-dependent transformation of nicotinic
acid adenine dinucleotide (NaAD) into the amide product NAD
via a two-step process. In the first step, a pyridine carboxylate
group is activated by adenylation followed by amidation via the
nucleophilic replacement of the adenylate moiety with ammonia
in the second step (Figure 1). This general mechanism involving an
adenylation step is shared by other ATP-dependent amidotrans-
ferase including GMP synthetase (GuaA), asparagine synthetase B
(AsnB) and Glu-tRNAGln amidotransferase (GatABC). Other
amidotransferase such as carbamoylphosphate synthetase (CarAB)
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both belonging to the ATP-grasp superfamily – and CTP
synthetase (PyrG) – belonging to the P-loop NTPase family – also
use ATP in their catalytic mechanism, which apparently includes
the hydrolysis of ATP to ADP rather than adenylation followed by
AMP release [15] (see Table 1). Another mechanistic feature
common for enzymes of this class is the in situ formation of
ammonia through deamidation of glutamine to glutamate by a
committed glutaminase domain (or subunit). The molecule of
ammonia is directly channeled from the glutaminase domain to
the amidation site in the synthetase domain (we will further refer to
them as G-domain and S-domain, respectively) without dissocia-
tion to the milieu. A compact two-domain arrangement allows
these enzymes to utilize glutamine in vivo (whereas in vitro they can
use both, glutamine and ammonia). This ability is of utmost
physiological importance, as the cellular level of free ammonia is
typically quite low due to its efficient capturing by glutamine
synthetase. The latter enzyme was historically considered as the
only ATP-dependent amidotransferase that utilizes ammonia (and
not glutamine) in vivo [16].
A similar two-domain arrangement is characteristic of NADS
enzymes that are present in Eukaryotes and in many (but not all)
Bacteria. The N-terminal G-domain of NADS belongs to the
nitrilase family of amidohydrolases [17]. It is structurally distinct
from functionally equivalent domains (or subunits) of other ATP-
dependent amidotransferases (see Table 1). The role of the G-
domain in the NADS mechanism of action was originally
described for the yeast enzyme (Qns1) [18,19] and later confirmed
for its human [20] and bacterial orthologs [10,21,22,23]. A series
of 3D structures of a glutamine-utilizing NADS from M. tuberculosis
provided mechanistic insights into functional coupling of its
glutaminase and synthetase activities [22,24].
On the other hand, many bacterial and nearly all archaeal
genomes lack a ‘‘long’’ (two-domain) form of NADS and, instead,
harbor a ‘‘short’’ NADS (e.g. as encoded by nadE gene in E. coli),
which includes only a core S-domain. Multiple representatives of
this single-domain NadE subfamily have been cloned and
characterized from various microbial sources both enzymatically
[25,26,27,28,29] and structurally [30,31,32,33,34,35]. All these
studies, including a first report on an archaeal NADS represen-
tative from Metanocaldococcus jannaschi in this work, demonstrated
that single-domain NADS can efficiently catalyze ATP-dependent
conversion of NaAD to NAD in vitro using only ammonia but not
glutamine.
These observations pose a fundamental question about the in
vivo source of the amide group for the NADS reaction catalyzed by
members of the single-domain NadE subfamily. At least two
possibilities are considered: (i) in vivo utilization of free ammonia,
which was previously considered a unique feature of glutamine
synthetase; (ii) in situ generation of ammonia from glutamine by a
committed (but yet unknown) glutaminase subunit, which is quite
common in other ATP-dependent amidotransferase families
(Table 1).
In the present study, by comparative genome analysis of , 800
prokaryotic genomes followed by focused experimental verification
we demonstrated that the vast majority of single-domain NADS
uses free ammonia in vivo as amide donor. We also found that a few
bacterial species encode a two-subunit form of NADS endowed
with glutamine-utilizing activity. Furthermore, in an attempt to
generalize our findings and improve NADS classification, we
identified sequence motifs discriminating between single-domain
(ammonia-utilizing) and two-domain or two-subunit (glutamine-
utilizing) NADS subfamilies. Finally, we propose an evolutionary
scenario where a single-component form (ammonia-utilizing) of
NADS represents the most likely ancestral form of NADS.
Materials and Methods
Materials and growth conditions
All bacterial strains and plasmids used in this study are listed in
Table S1. Selected mutant strains of Salmonella typhimurium LT2
deficient in ammonia utilization (as described in [36]) were kindly
provided by Dr. Sidney Kustu (UC Berkeley). Strains were grown
in Luria Bertani (LB) or minimal media (9) supplemented with
glutamine (5 or 20 mM) or ammonia (20 mM). For DNA
manipulations, restriction endonucleases were purchased from
Fermentas. DNA was amplified using Pfu Ultra II Fusion DNA
polymerase (Stratagene). Plasmids were isolated using the Wizard
Plus SV Miniprep Kit (Promega), and PCR products were purified
using the Wizard SV Gel and PCR Clean-Up System (Promega).
Primers used for molecular cloning and sequencing (including
those for the sequencing of the nadE gene from nit mutants of S.
typhimurium) are listed in Table S2. Sequencing of gel-purified
DNA amplification products was performed by Eton Bioscience.
Figure 1. Scheme of the two-step reaction catalyzed by NAD synthetase.
doi:10.1371/journal.pone.0039115.g001
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purification
The nadE gene encoding NADS of S. typhimurium LT2 (locus tag:
STM1310, st_NADS), wild-type and nit mutant strains were
amplified by polymerase chain reaction from genomic DNA and
cloned in pET15b vector as a fusion with an N-terminal His6-tag
(Novagen). A two-gene operon from Thermus thermophilus HB27
encoding a predicted two-component tt_NADS comprised of the
core synthetase or S-subunit (TTC1538) and a putative glutamin-
ase or G-subunit (TTC1539), was cloned in a pET-derived vector
[37] adding His6-tag to the N-terminus of the first gene of the
operon. Individual genes encoding S-subunit of tt_NADS and
mj_NADS from Metanocaldococcus jannaschi DSM (MJ1352) were
cloned in the same vector. All recombinant proteins were
overexpressed in E. coli BL21/DE3 and purified to homogeneity
using standard protocols, e.g. as described in [38]. Typically, cells
were grown in LB medium to OD600 of ,0.8–1.0 at 37uC,
induced by 0.2 mM IPTG, and harvested after 12 h of shaking at
20uC. Proteins were purified from 1-6 L cultures by chromatog-
raphy on a Ni-NTA agarose column followed by gel filtration on a
HiLoad Superdex 200 16/60 column (Pharmacia) with an AKTA
FPLC system.
Activity assays and steady-state kinetic analysis
A continuous assay for NADS activity was based on enzymatic
coupling of NAD production (from NaAD and ammonia or L-
glutamine) with its conversion to NADH by alcohol dehydroge-
nase and monitored at 340 nm (e=6.22 mM
21 cm
21)a s
previously described [21]. The specific activity assays were carried
out at 37uC in a buffer containing 10 mM MgCl2,4 6 m M
ethanol, 16 mM semicarbazide (or 2 mM NaHSO3 in case of
glutamine utilization), 100 mM HEPES, pH 7.5, in the presence
of saturating concentrations of all substrates, 2 mM ATP, 2 mM
NaAD, and 4 mM NH3 (or Gln). A direct HPLC-based assay was
used to assess substrate specificity of thermostable mj_NadE. The
reaction mixture contained 100 mM HEPES, pH 7.5, 10 mM
MgCl2, 2 mM ATP, 2 mM NaAD (or NaMN), and 4 mM NH3
(or Gln). After 30 min of incubation at 70uC, protein was removed
by micro-ultrafiltration using Microcon YM-10 centrifugal filters
(Amicon), and filtrates were analyzed on 5064.6 mm C18 column
(Supelco) as described [11].
To determine the steady-state rate constants, two substrates (e.g.
NaAD and ATP) were kept constant at saturating concentration,
whereas the third substrate (e.g. ammonia or glutamine) was
varied over a relevant concentration range. For example,
ammonia ranged from 0.1 to 4 mM for wild type st_NadE, and
from 1 to 40 mM for the mutant st_NadE. Measurements were
performed in triplicates, and initial velocity data were fitted to the
standard Michaelis-Menten equation using GraphPad Prism
software package to obtain Km and kcat values.
Quantitative RT-PCR analysis
Total mRNA was isolated from S. typhimurium LT2, nit11 and
SK51 cells grown in either rich (LB) or minimal media plus 5–
20 mM glutamine or 20 mM ammonia using the SV total RNA
isolation system (Promega). Reverse transcription was performed
in the presence of random primers, after DNase treatment
(Promega), using SuperScript II reverse transcriptase (Invitrogen).
In order to check for DNA contamination, control reactions were
carried out in the absence of reverse transcriptase. Real-time PCR
was performed using SYBER GreenER qPCR supermix universal
(Invitrogen) and specific primers listed in Table S2 amplifying
short region of NAD synthetase gene (nadE) and gapA that was used
as internal standard. Amplification conditions were as follows:
15 min at 95uC; 30 s at 95uC, 1 min at 56uC, 30 s at 72uC for 40
cycles and were carried out in a Stratagene Mx3000.
Bioinformatics analyses
Phylogenomic distribution and genomic context of NADS-
encoding genes (fusion events, chromosomal clustering, and co-
occurrence of glutaminase and synthetase components) were
analyzed using a collection of over 800 completely sequenced and
annotated genomes in the SEED database [39] (see Table 1 and
Table S3). For comparative purposes, a similar (albeit less detailed)
Table 1. Genomic arrangement of the synthetase and glutaminase components in NAD synthetase and other families of ATP-
dependent amidotransferases.
Enzymes
Gene
names
1 Pathway
Glnse
class
2 Arrangement of synthetase and Glnse components
3 genomes
Fusion Cluster Remote No Glnse
NAD synthetase nadE NAD IV 54 1 1 44 886
Asparagine synthetase B asnB Asn II 100 - - - 700
CTP synthetase pyrG CTP I 100 - - - 800
GMP synthetase guaA GMP I 100 - - - 730
Formylglycinamidine
ribonucleotide
amidotrans.
purL Purines I 52 25 23 - 660
Anthranilate synthetase trpDE Trp I 5 70 25 - 570
Carbamoyl-phosphate
synthetase
carAB Pyrimidines I 1 72 27 - 600
Glu-tRNA
Gln
amidotransferase
gatABC Translation III 0 67 33 - 490
1Gene names are as in E. coli except gatABC and yaaDE that are as in B. subtilis (not present in E. coli).
2 A current classification of glutaminase domains (subunits) of
amidotransferases includes four classes of nonhomologous enzymes: Class I (contains a catalytic triad in the active site); Class II (contains a catalytic Cys at the N-
terminus); Class III (a relatively poorly explored glutaminase subunit of GatABC complex); and Class IV (nitrilase-like glutaminase component of NADS).
3 Percentage (%)
of total number of arrangements within analyzed genomes.
doi:10.1371/journal.pone.0039115.t001
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amidotransferases and these data are also included in Table 1. A
species tree constructed based on the 16S rRNA marker was taken
from the MicrobesOnline resource [40]. Annotated NADS genes
were loaded into an in-house Oracle XE database [41] and
mapped into the species tree using ad-hoc PL/SQL scripts.
Multiple sequence alignments of S- and G-domains were
constructed using Muscle [42] by the following procedure: (i) first,
all sequences were clustered into compact groups based on an
approximate tree constructed from a multiple alignment obtained
by a conventional procedure. Phylogenetic trees were built by
FastTree [43] and the topology of the trees was additionally
confirmed using RAxML [44]; (ii) poorly aligned blocks, the
regions with numerous gaps, were cut out from the multiple
alignments of each gene cluster; (iii) all clusters were merged into
one alignment by the profile-to-profile aligning method incorpo-
rated in Muscle. Species and gene trees were visualized and color-
highlighted using Dendroscope [45]. For the purpose of evolu-
tionary signature analysis the second step in this procedure was
omitted. An ancestral character reconstruction was performed by
the maximum parsimony method from the Mesquite package [46].
Structural Modeling of the T. thermophilus 3D structure was
obtained by Modeller [47] using the Chimera interface [48].
Contacts between synthetase and glutaminase domains were
recognized using Chimera with default parameters (van der Waals
surface overlap $2 0.4 A ˚).
Results
NADS family phylogenomic distribution and classification
Among , 940 complete genomes included in the manually
curated metabolic subsystem ‘‘NAD and NADP metabolism’’ [49]
in the SEED database [39], at least one form of NADS was found
to be present in 886 genomes (94%) including 814 bacterial, 56
archaeal and 16 eukaryotics genomes (Table S3). Among 56
species lacking NADS are those with rare NADS-independent
variants of the NAD synthesis, such as Haemophilus influenzae [50]
and Francisella tularensis [11], and some obligate intracellular
endosymbionts, such as Chlamydia and Rickettsia, where the entire
NAD biosynthetic machinery is replaced by a unique ability to
salvage NAD from the eukaryotic host cell [49].
All NADS-encoding genes can be classified as one of the two
forms: the two-domain form comprised of the N-terminal
synthetase (S-domain) and C-terminal glutaminase (G-domain),
and the single S-domain form lacking the G-domain (Figure 2).
The first form is characteristic of all Eukaryotes and many diverse
bacterial (but not archaeal) lineages (termed here type F for Fused).
The second form was further classified to three types depending on
the presence or absence and chromosomal arrangement of a
distinct gene encoding a putative G-subunit. The latter was
identified by close homology with the G-domain of type F NADS in
a limited number of bacterial and archaeal species, either clustered
on the chromosome with a single-domain S-subunit (termed type C
for Clustered) or located remotely (type R for Remote). However, in
the overwhelming majority of genomes encoding a single-domain
NADS (such as NadE in E. coli) no candidate G-subunit could be
detected (termed type N for None) (Figure 2 and Table S3).
As already mentioned, all previously characterized type F NADS
enzymes were shown to efficiently utilize glutamine (in addition to
ammonia) for the NaAD transamidation in vitro. Based on an
analogy with several other ATP-dependent amidotransferase
families (Table 1) that can accommodate all three types (F, C
and R) of the genomic arrangement for their glutaminase
components (domains or subunits), we hypothesized that at least
type C (and possibly type R) NADS enzymes can form a glutamine-
utilizing complex comprised of S- and G- subunits. To test this
hypothesis we cloned, expressed, purified and performed enzy-
matic characterization of the predicted two-component (type C)
NADS from Thermus thermophilus HB27 (tt_NADS) comprised of S-
and G-subunits encoded within a single operon (see below).
The glutamine-utilizing ability of type F, C (and likely R) NADS
is consistent with the anticipated role of glutamine as a universal in
vivo source of the amide group for most ATP-dependent
amidotransferases including NADS (Table 1). At the same, this
question remained open for type N enzymes. Multiple representa-
tives of the type N NADS from diverse bacterial species were
previously characterized as strictly ammonia-utilizing in vitro. Type
N NADS enzymes characteristic of Archaea could be tentatively
assigned as ammonia-dependent, but to our knowledge, this
conjecture has not been experimentally tested prior to this study.
To fill-in this knowledge gap we have cloned, expressed, purified,
characterized and confirmed ammonia-dependence of NADS
from Methanocaldococcus jannaschii (see below).
Our exhaustive genome context analysis [51] (including the
analysis of operons, regulons, co-occurrence profiles combined
with distant homology-based functional assessment) failed to
identify any novel (nonorthologous) types of the G-subunit in
neither Bacteria nor Archaea. This observation supports (albeit
does not prove) a hypothesis originally derived from the genetic
study in Salmonella that NadE is directly utilizing free ammonia as
a nitrogen donor [16]. This study showed that a growth phenotype
caused by mutations in the nadE (nit) locus could be compensated
by increasing ammonia (but not glutamine) level in the media. To
test whether the observed phenotype is indeed due to the impaired
ability of NadE to directly utilize ammonia rather than pair up
with an unknown glutaminase, we aimed to clone, express, purify
and characterize the NadE enzyme from the Salmonella nit mutant
(see below).
The capability to directly utilize ammonia in vivo for the
amidotransferase reaction would make the NadE subfamily only a
second known case after glutamine synthetase. To assess whether
this feature could be generalized beyond a single species, we
performed a more detailed comparative phylogenetic and
evolutionary analysis of the NADS family (as described below).
A two-subunit NADS from T. thermophilus (tt_NADS) can
utilize glutamine as a nitrogen donor
The co-expression in E. coli of the two genes forming an operon
(TTC1538 – TTC1539) in T. thermophilus showed that their
products encoding putative S- and G- subunit of NADS form a
tight complex and tend to co-purify on Ni-NTA (Figure 3A) and
gel filtration (Figure 3B) chromatography. The SDS-PAGE
analysis is suggestive of 1:1 stoichiometry. The enzymatic
characterization of this complex confirmed its NADS activity
and the ability to use both, ammonia and glutamine as amide
donors. In contrast, the S-subunit alone, when expressed and
purified as a single gene, had a comparable NADS activity only
with ammonia (Figure 3C) showing Km values very close to typical
bacterial NadE enzymes [25,52]. Notably, even for the two-
subunit (G/S) enzyme, the substrate preference was still in favor of
ammonia over glutamine (,50-fold), suggesting a theoretical
possibility of using both substrates in vivo. On the other hand, the
preference for ammonia over glutamine reported for a typical
NadE enzyme (e.g. , 2,500 fold for the NadE from Pseudomonas sp.
[25] is substantially higher. In fact, even a low NadE activity
observed with glutamine is likely due to its spontaneous hydrolysis
and/or some contamination by free ammonia. Overall, the
obtained results provided the first experimental verification of
Phylogenomics of the NAD Synthetase Family
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NADS enzymes (Figure 2).
A single-domain NADS from M. jannaschii (mj_NADS)
uses ammonia as a nitrogen donor
Members of the NadE subfamily are found in Archaea but no
study on a NADS enzyme from an archaeal representative has
been reported so far. In fact, the very existence of NAD synthetase
function in Archaea could be questioned as in all of them (50 out
of 50 genomes analyzed) a typical bacterial NadD enzyme
(converting the NaMN precursor to the NaAD substrate of
NADS) is replaced by a distantly homologous NadM. Members of
NadM family (that are also present in some Bacteria), unlike
NadD, can effectively utilize an amidated pyridine nucleotide,
NMN, thus providing an alternative (NADS-independent) route to
Figure 2. Genomic arrangements of functionally coupled glutaminase (GAT) and synthetase (NADS) components. Comparative
genome analysis revealed 4 different genomic arrangements of GAT and NADS components: a) two domain organization (fusion); b) physical
clustering; c) remote occurrence; d) absence of glutaminase. Their relative distribution across Archaea, Bacteria, and Eukaryotes is also shown (left
side).
doi:10.1371/journal.pone.0039115.g002
Figure 3. Biochemical characterization of T. thermophilus glutaminase and NAD synthetase subunits. SDS-page analysis of Ni-NTA
affinity column (A) and gel filtration chromatography (B) elution fractions show that His-tagged recombinant T. thermophilus NADS and untagged
GAT tend to co-purify. (C) Kinetic characterization of T. thermophilus S-subunit and G/S complex.
doi:10.1371/journal.pone.0039115.g003
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tularensis, a replacement of NadD with NadM is accompanied
by a functional adaptation of the NadE homolog as NMN
synthetase (NMNS), with only a marginal NADS activity [11]. On
the other hand, we have reported that archaeal NadM [12] is a
bifunctional NMN/NaMN adenylyltransferase, which, at least
theoretically, may operate in conjuction with either NMNS or
NADS. For example, a bifunctional NadM acts in concert with a
conventional (type F) NADS in another unusual bacterial NAD
network of Acinetobacter sp. [10]. To clarify the functional activity
of the archaeal NadE sub-family, we have cloned and overex-
pressed in E. coli a gene MJ1352 encoding a putative NADS from
M. jannaschii. The kinetic parameters and substrate specificity of
the purified recombinant mj_NADS were evaluated with respect
to NaAD and NaMN as substrates with ammonia as amide donor
(4 mM) and saturating ATP (2 mM). This analysis revealed a
robust ammonia-dependent NADS activity (Km for NaAD
0.1360.02 mM and kcat of 0.2060.01 s21). No appreciable
NMNS activity and no NADS activity with glutamine as the
amide donor could be detected. Overall, this analysis confirmed
classification of the archaeal NadE, together with bacterial
members of this subfamily, as ammonia-utilizing (type N) NADS.
Kinetic properties of a mutant single-domain NADS from
S. typhimurium (st_NADS) are consistent with its
physiological role in direct utilization of ammonia in vivo
Salmonella nit mutants that were previously characterized as
defective in nitrogen assimilation despite normal levels of
ammonia assimilatory enzymes [36], provided us with a valuable
case study to further address the question of the in vivo amide
donor characteristic of NadE subfamily. Whereas both classes of
mutants described in the original study, those induced by ICR
(SK51) or by nitrosoguanidine (nit11), were genetically mapped
within the nadE locus, the exact nature of these mutations has not
been established. Amplification and sequencing of the respective
mutant loci revealed two types of genetic lesions: (i) a deletion of a
single nucleotide (G) in the promoter region upstream of the
predicted -35 box, and (ii) a point mutation at the nucleotide 143
(G to A) replacing Ser-84 residue with Asn (Figure 4A). Therefore,
a reported loss of the NADS activity could be expected to occur at
the transcriptional level for the first type, and at the level of
enzymatic properties for the second type of mutations. Indeed, a
quantitative RT-PCR confirmed a substantial (, 100-fold) drop of
the nadE mRNA level in SK51 compared to nit11 or wild-type S.
typhimurium (Figure 4B). Importantly, increasing ammonia or
glutamine in the media did not have any effect on the relative
Figure 4. Analysis of Nit11 and SK51 S. typhimurium mutant strains. (A) Schematic of S. typhimurium nadE mutant strains. Nit11 mutant
features a missense mutation at nucleotide 143 yielding the amino acid substitution AN. SK51 mutant features a single nucleotide deletion (G at
position – 51 considering as +1 the first base of the start codon) that is just upstream of the -35 box regulatory region of the promoter. Predicted
regulatory sequences are indicated in the bottom line. (B) Relative expression level of nadE in the wild type and in the two classes of mutants nit11
(S48N) and SK51 in four different growth conditions: rich medium (1), minimal medium supplemented with 20 mM NH3 (2), MM supplemented with
5 mM (3) or 20 mM (4) glutamine. (C) Kinetic characterization of wild type and S48N S. typhimurium NAD synthetase. Initial rates were measured by
spectrophotometrical coupled (SPEC) assays. The kinetic parameters Km and kcat are apparent values determined at fixed (saturating) concentrations
of co-substrates. For fixed substrates, concentrations were: 2 mM ATP, 2 mM NaAD, and 40 mM NH3. Errors represent standard deviation.
doi:10.1371/journal.pone.0039115.g004
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of growth phenotype is not due to the regulation on the level of
transcription, but rather due to overcoming a competition for
nitrogen source between a severely suppressed NADS and a robust
glutamine synthetase (GlnA). The latter interpretation is consistent
with the reported compensatory effect of the glnA mutation [36].
To determine the effect of the mutation nit11 on the enzyme
function, wild type st_NADS and S48N mutant were overex-
pressed in E. coli, purified and their apparent steady-state kinetic
parameters were determined toward ATP, NaAD, and NH3
(Figure 4C). The wild-type enzyme had kinetic parameters very
close to those reported for E. coli NadE [52]. The most dramatic
difference from S48N mutant was observed at the level of the
apparent Km value for ammonia, which was , 70-fold higher for
the mutant st_NADS compared to the wild-type enzyme. This
finding provides a straightforward interpretation for the observed
growth phenotype of nit11 strain, which could be compensated for
by increasing the concentration of ammonia in the media [36].
Notably, the mutated residue is a part of the conserved motif
SGGXDST characteristic of the N-type ATP pyrophosphatase
family [14]. Based on the NadE structure [34], it is located in the
vicinity of the active site, which is consistent with the observed
effect on the NADS activity.
Therefore, the established effect of mutation on enzyme affinity
toward ammonia taken together with the described ammonia-
dependence of the respective mutant strain provided additional
support to the hypothesis that the single-domain NADS enzymes
of the NadE subfamily utilize ammonia, and not glutamine, as a
source of the amide group in vivo.
Identification of NADS structural elements associated
with glutamine utilization capabilities
A projection of the classification described above onto the
NADS family phylogenetic tree (Figure 5A, for details see
Figure S1) shows remarkable consistency for the three branches
I–III covering all enzymes of the type F. While most of NADS
sequences within branches IV–VII belong to the type N,
representatives of the type C (and R) are found intertwined among
them within branches IV and V. Therefore, sequence-based
discrimination between genuine single-component (ammonia-
utilizing) NADS and two-subunit (glutamine-utilizing) enzymes
represents a challenge. It is particularly important since many
genomes contain distant representatives of the nitrilase family with
yet unassigned functions that could be considered candidate G-
subunits for NADS enzymes presently classified as type N.
To address this challenge we aimed to identify the hypothesized
signature sequence elements (motifs) characteristic of two-compo-
nent glutamine-utilizing NADS enzymes distinguishing them from
single-component ammonia-utilizing enzymes. Identification of
such motifs would help to generalize our findings and improve the
NADS classification. For this purpose we combined comparative
sequence analysis with available 3D structural data. Each of the
seven branches of the NADS phylogenetic tree is represented by at
least one of 18 reported 3D structures (Figure 5A). Detailed
examination of the key residues implicated in substrate, cofactor
and metal ion binding sites [22,30,31,32,33,34,35,53] (Table S4)
failed to identify any residues that are distinct between the two
groups of NADS enzymes: (i) glutamine-utilizing (type F, C and R)
and (ii) ammonia-utilizing (type N), but conserved within each
group. Likewise, no residues significantly correlating with the
separation of , 800 analyzed sequences between the two groups
could be identified by the specificity-determining position predic-
tion method implemented in the SDPpred algorithm [54]. One
limitation of this method (which was successfully used by us for
functional classification of other protein families, e.g. [55]), is the
required elimination of poorly aligned regions containing major
gaps. The inspection of such regions removed from NADS
multiple alignment showed that they mostly belong to the surface
loops that are generally known to accumulate frequent insertions
and deletions [56] contributing to the adaptive evolution of
protein-protein interactions interface [57].
We hypothesized that structural elements discriminating
between the two NADS groups may reside within the looping
regions of enzymes from the first group that are responsible for the
interactions between the S- and G-domains (or subunits), and that
do not have corresponding regions in the single-component
enzymes. Thus, all four structural components of an S-domain
comprising an interaction interface with the G-domain: the a9,
a18 and a20 helices and an extended C-terminal loop (as
identified in the original M. tuberculosis NADS structure, Figure 6),
appear to play the same role in other reported type F NADS
structures from Cytophaga hutchinsonii (PDB:3ILV), and Streptomyces
avermitiis (PDB:3N05). The respective regions of the amino acid
sequence are conserved in all three branches (I–III) of the
phylogenetic tree covering type F enzymes. On the other hand, two
of these structural elements, the a18 helix and the C-terminal
loop, are absent in all five reported 3D structures from the major
branch VI representing type N single-domain enzymes, including
st_NADS. A multiple alignment rebuilt to include all variable
regions confirms that these structural elements are absent in all
representatives of this branch (Table 2 and Figure S2). Of these
two elements, the a18 helix is detectable in three reported 3D
structures from the branch IV and V. However, none of these
structures include a C-terminal loop. The complete multiple
alignment suggests that the latter is a signature element
distinguishing predicted two-subunit enzymes mapped in these
two branches (such as tt_NADS in branch IV) from their single-
component counterparts (such as mj_NADS in the predominantly
archaeal branch V, see Figure S3).
Overall, a mandatory presence of all signature elements listed
above (see Table 2) as a necessary and sufficient requirement
distinguishing all three types of two-component enzymes from
single-component ones was confirmed for nearly all analyzed
sequences. The only two exceptions were NADS enzymes from
Vibrio alginoliticus and Desulfococcus oleovorans (branches VI and VII,
respectively) originally classified as type R based on the presence of
a putative G-subunit ortholog in the respective genomes.
Evolution of the NADS family
A mosaic distribution of different NADS forms over the species
tree (Figure 5B, for details see Figure S4) implies a complex
evolutionary history of this ancient enzyme family. The most
intriguing question is whether a two-component (glutamine-
utilizing) or a single-component (ammonia-utilizing) NADS
represents the most likely ancestral form. Was it a two-domain
form in the Last Universal Common Ancestor (LUCA), which
experienced domain fission in the archaeal and some bacterial
lineages? Or a single-domain NADS was fused with a nitrilase
homolog in one of the deep-branching Bacteria and then passed
onto an ancestor of the modern Eukaryotes? The analysis of the
NADS phylogenetic tree built from the multiple alignment of S-
components only (Figure 5A and Figure S1) shows a complete
separation of fused enzymes (type F) from all other NADS (types C,
R and N). It suggests that an underlying fusion or fission event
could have occurred only once at an early stage of the family
evolution. The parallel analysis of the phylogenetic tree built from
the multiple alignment of G-components alone (domains and
subunits) (Figure S5) revealed a strikingly similar topology with the
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observation points to co-evolution of S- and G-components, and
it confirms the conjecture about the unique nature of the ancient
fusion/fission event. Further detailed analysis of the NADS tree
topology within each kingdom allowed us to reject fission of an
ancestral two-domain NADS as an unlikely evolutionary scenario
compared to a more likely fusion of ancestral S- and G-subunits.
Indeed, a single-domain NADS is a predominant and obviously
ancestral form for the Archaea. Few cases of type F NADS
observed in Archaea (e.g. Methanocalleus marisnigri, Methanosaeta
thermophila) clearly result from a relatively recent horizontal gene
transfer (HGT), most likely from Cyanobacteria. This conclusion
was also formally supported by the reconstruction of the ancestral
character using the maximum likelihood method (Figure S6). The
topology of spreading of NADS forms over diverse groups of
Bacteria (Figure 5B) is inconsistent with the origination of either
form from a relatively recent HGT. Moreover, an observation that
the bacterial single-domain NADS branch IV is the closest to the
archaeal branch V (see Figure 5A), suggests that a possible root of
the NADS tree and, thus, a hypothetical NADS ancestral form
would be single-domain. This conjecture is consistent with the
enrichment of branch IV with enzymes from deep-branching
Figure 5. Phylogenetic analysis of NAD synthetase enzyme family. (A) Schematic representation of NAD synthetase phylogenetic tree (full
version is in Figure S1) constructed based on synthetase domain. Defined types of NAD synthetase genes – ‘‘Fused’’ (type F), ‘‘Clustered’’ (type C),
‘‘Remote’’ (type R) and ‘‘None’’ (type N) are highlighted by red, green, cyan and magenta colors, respectively. The whole tree is partitioned by
topology into clusters, which are designated as I–VII branches. (B) Schematic representation of species tree with mapping of NAD synthetase gene
types (full version is in Figure S2). Genomes containing single NAD synthetase gene of F, N, C, and R types are depicted by red, green, cyan and
magenta colors, respectively. Genomes that possess more than one NAD synthetase gene are divided into ‘‘multiple F’’, ‘‘multiple N’’, ‘‘single F –
single N’’ and ‘‘all others’’ genome groups, which are highlighted by dark red, dark green, orange and yellow colors, respectively.
doi:10.1371/journal.pone.0039115.g005
Figure 6. Contact regions between synthetase (blue) and glutaminase (cyan) domains in NADS from Mycobacterium tuberculosis. The
majority of interacting residues were found in following structural regions-the a9, a18 helices and the extended C-terminal loop, which are
highlighted by pink, green and yellow colors, respectively.
doi:10.1371/journal.pone.0039115.g006
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enzymes also belong to the branches IV and V, pointing to an
ancestral hypothesized character recruitment of a G-subunit and
its operonization with an S-subunit. The subsequent evolution of a
two-component form followed by multiple gene loss and acqui-
sition events in different lineages generated the complex
taxonomic distribution of NADS forms in Bacteria. A more
detailed analysis of this distribution for selected taxonomic groups
(those containing tt_NADS and st_NADS described in this study) is
provided in Supporting Information (Text S2 and Figure S7). The
topology of the two-domain NADS sub-tree clearly indicates that
its eukaryotic branch II originates from the bacterial branch I.
This branching point (supported by a bootstrap value of 97%) is
sufficiently remote from the possible root arguing in favor of
bacterial origin of the ancestral eukaryotic NADS.
Based on these observations, we propose an evolutionary
scenario for the NADS family illustrated in Figure 7. Briefly, an
ancestral NADS in the last universal common ancestor (LUCA)
was likely a single-domain ammonia-utilizing enzyme. A two-
domain glutamine-utilizing form emerged at an early stage of
evolution, possibly via intermediate state of clustering of the S- and
G-subunits in one operon [58]. It could either happen in Bacteria
shortly after separation from Archaea, or before this separation
and then lost by the common ancestor of Archaea. The two-
domain NADS was acquired by the common ancestor of
eukaryotes (LECA, [59]).
Discussion
In this study we addressed a fundamental question about the
physiological donor of the amide group for the ATP-dependent
amidation of NaAD to NAD, the last step in the biosynthesis of
this ubiquitous redox cofactor, which is catalyzed by divergent
members of the NADS enzyme family (Figure 1). In contrast to
other classes of ATP-dependent amidotransferases, which are
typically comprised of two components (domains or subunits)
endowed with synthetase and glutaminase activities, all archaeal
and nearly half of the bacterial NADS appear to be comprised of
just a single synthetase (S-) domain (Figure 2, Table S3). Multiple
representatives of the latter subfamily from a variety of diverse
Bacteria (e.g. NadE from E. coli) were shown to utilize only
ammonia (and not glutamine) as an amide donor in vitro, whereas
the situation in the cells remained open for alternative interpre-
tations. Among them, the two most plausible ones were: (i) the
existence of a yet uncharacterized glutaminase (G-) subunit
(instead of a G-domain) that would allow the NadE-type enzymes
to utilize glutamine just as the two-domain NADS and most other
ATP-dependent amidotransferases; (ii) the direct utilization of
ammonia as the nitrogen donor in vivo, which was traditionally
considered a unique feature of glutamine synthase (GlnA in E. coli).
Among the arguments in favor of the first scenario was a
presumably limited availability of free ammonia in the cells as well
as a conventional two-component arrangement typical for the
entire class of ATP-dependent amidotransferases (Table 1).
Arguments supporting the second possibility were an apparent
absence of candidate genes for G-subunits in the overwhelming
majority of the genomes containing single-domain NADS, and
indirect experimental evidence obtained by genetic methods in
Salmonella [16].
In this study we further explored both plausible scenarios by
combining bioinformatics with focused experimental analysis.
Remarkably, in a comparative genome analysis of over eight
hundred prokaryotic genomes, we found several cases of genomic
co-occurrence of distinct genes encoding putative orthologs of
both, S- and G-domains (Figure 2). The observation that in some
cases these genes are located next to each other on the
chromosome, hence forming putative operons (type C in Figure 2),
allowed us to suggest the existence of two-subunit glutamine-
utilizing NADS enzymes. This hypothesis was experimentally
verified for a complex of S- and G-subunits encoded by the
TTC1538-TTC1539 operon from T. thermophilus. This finding
additionally generalized to a small group of genomes where the
putative orthologs of S- and G-subunits occur in remote positions
of the genome (type R) provides supporting evidence for the first
scenario.
However, this scenario cannot be directly applied to nearly half
of bacterial genomes that contain no putative orthologs of the G-
subunit. Most archaeal genomes also contain orthologs of S-
subunit but no orthologs of the G-subunit further expanding the
taxonomic distribution of putative single-domain (type N) NADS
enzymes. Since the experimental characterization of archaeal
NADS has not been previously reported, here we filled this gap by
confirming ammonia-dependent NADS activity of the represen-
tative recombinant protein mj_NADS from M. jannaschii. Further
Table 2. Distribution of two-component glutamine-utilizing
NADS signature elements across phylogenetic branches.
branches a9 helix a18 helix
Extended C-
terminal loop
I ++ +
II ++ +
III ++ +
IV ++ + /2
V ++ + /2
VI + 22
VII + 22
doi:10.1371/journal.pone.0039115.t002
Figure 7. Tentative evolutionary scenario of one- and two-
domain form of NAD synthetase enzyme family.
doi:10.1371/journal.pone.0039115.g007
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over the entire collection of bacterial and archaeal genomes
integrated in the SEED database [39] revealed no plausible
candidate gene for an alternative (nonorthologous) G-subunit.
This is in contrast with other ATP-dependent amidotransferases
whose G- and S-subunits are typically encoded within the same
operon (Table 1), arguing in favor of the second possible
interpretation, i.e. a direct utilization of ammonia by type N
bacterial and archaeal NADS enzymes. A similar suggestion was
previously reported based on the analysis of nit mutants of S.
typhimurium with deficient nitrogen assimilation (from glutamine
and ammonia) due to mutations in the nadE locus [16]. Here, we
provide further support to this hypothesis by the identification of
specific lesions in two selected mutant strains (nit11 and SK51),
and establishing a molecular mechanism underlying the observed
phenotype. Indeed, nit11 featured a mutation of a highly
conserved amino acid in the active site of bacterial NAD
synthetase (S48N), which impaired the enzyme’s ability to use
ammonia (Km for ammonia increased ,100-fold compared to the
wild type, figure 4C). Based on the published structural analysis,
this conserved residue participates in the stabilization of the
adenylate intermediate (20), which, according to our data,
increased the ammonia requirement in the mutant enzyme. The
mutant of the second class, SK51, featured a deletion in the
promoter region that dramatically decreased the nadE gene
expression. Our results suggest that the ability of these mutants
to restore normal growth in the presence of high ammonia
supplementation is not due to upregulation of gene expression but
rather to the increased availability of the ammonia substrate
necessary to overcome the competition with a fully active
glutamine synthetase (GlnA). Indeed, these nit mutations could
be suppressed by a mutation in glnA gene [36]. Overall, these data
strongly support the hypothesis that at least some members of the
NadE subfamily directly use ammonia, and not glutamine, as a
source of the amide group in vivo.
A more detailed comparative sequence and 3D structure
analysis of the NADS family allowed us to establish signature
motifs that help to distinguish between single-component and less
obvious cases of two-component (type R) NADS enzymes. These
motifs (a9 and a18 helices, and extended C-terminal loop)
comprising the interaction interface between S- and G-domains
or subunits are invariantly present in all diagnosed two-component
NADS, but at least some of them are absent (or substantially
changed) in single-component enzymes (see Table 2 and Text S1).
For practical purposes, the identified signature motifs are expected
to improve quality of homology-based automated assignment of
new members of NADS family as glutamine- or ammonia-utilizing
enzymes. This is of particular utility for metagenomic data analysis
when the genomic co-occurrence of S- and G-subunits cannot be
directly assessed.
The NADS family features a complex phylogenetic distribution
pattern of single-component and two-component forms. Thus,
Eukarya and Archaea form two compact groups comprised
exclusively or almost exclusively of single-domain or two-domain
forms, respectively. On the other hand, Bacteria feature a mosaic
distribution of both forms pointing to a complex evolutionary
history. Based on the combined analysis of the NADS and species
trees (Figure 5 and Figures S1 and S2) we propose the following
evolutionary scenario (Figure 7): (i) a single-domain ammonia-
utilizing NADS was the ancestral form present in the LUCA; (ii) a
two-subunit glutamine-utilizing form evolved via recruitment,
specialization and operonization of a nitrilase homolog (G-subunit)
at an early stage of the NADS-family evolution; (iii) a two-domain
form emerged as a fusion of the S- and G-subunits in one of the
deep-branching bacterial lineages shortly after separation from
Archaea (alternatively it could have emerged before separation but
lost by the universal ancestor of Archaea); (iv) Archaea maintained
the indigenous single-domain NADS with a few exceptional cases
of HGT of a two-domain NADS from Bacteria; (v) the mosaic
distribution of single-domain and two-domain forms resulted from
a combination of HGT and gene loss without additional fusion or
fission events; (vi) Eukarya inherited and adopted the bacterial
two-domain NADS. A proposed evolution of the ability to utilize
glutamine as an alternative amide donor appears to be reflected in
the glutamine vs ammonia preference reported for diverse two-
component NADS enzymes. Thus, a presumed ancestral two-
subunit form represented by NADS from T. thermophilus charac-
terized in this study displays a 50-fold preference for ammonia
over glutamine substrate. The NADS from Thermotoga maritima
representing branch III, the most ancestral of the three branches
containing two-domain forms, shows an equal preference for both
glutamine and ammonia (40). Interestingly, in addition to the two-
domain form, T. maritima contains a single-domain NADS of the
NadE subfamily supporting a possible physiological relevance of
both glutamine and ammonia as NADS substrates. Finally,
characterized two-domain enzymes representing the other two,
apparently more specialized branches I and II, show a clear
preference for glutamine over ammonia, ,4-fold for NADS from
M. tuberculosis [22] and ,6-fold for human [20,60].
In summary, a comparative genome analysis of NAD synthetase
allowed us to predict and experimentally confirm that i) ammonia
serves as the in vivo nitrogen donor for one-domain NADS ii) NAD
synthetase and glutaminase enzymes, encoded by clustered genes,
form a tight functional complex endowed with glutamine-utilizing
capability as characteristic of two domain NADS form. These
results allowed us to tentatively generalize the existence of a two-
subunit glutamine-utilizing NADS toward those bacterial genomes
with a remote chromosomal arrangement of synthetase and
glutaminase, as further supported by our identification of
glutamine-utilization motifs in the extended group of two-
components NADS. Lastly, we propose that one-domain ammo-
nia-utilizing NADS was the ancestral NADS form. Bacteria could
have engineered the ability to utilize glutamine via an intermediate
state of clustering up to the fusion with a recruited nitrilase
homolog, an ancestor of the modern G-domain of NADS.
Supporting Information
Figure S1 Full NAD synthetase phylogenetic tree con-
structed based on synthetase domain. Color scheme is from
figure 5A.
(TIF)
Figure S2 Structural/sequence comparison of the pro-
tein segments involved in synthetase-glutaminase inter-
actions. The alignment is based on NAD synthetase enzymes,
and only representatives of the main branches of NADS tree are
illustrated. It can be noted the presence of a9 helix in all groups,
a18 helix in branches I-V only and the extended C-terminal loop
pervasively in branches I–III and eventually in branches IV–V.
(TIF)
Figure S3 Glutamine-utilizing signature elements in
NAD synthetase enzymes from IV–V branches. The
striking correlation of the presence of the extended C-terminal
loop with types C and R enzymes can be observed.
(TIF)
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